190 related articles for article (PubMed ID: 24400085)
1. Results of the Dyslipidemia International Study (DYSIS)-Middle East: clinical perspective on the prevalence and characteristics of lipid abnormalities in the setting of chronic statin treatment.
Al Sifri SN; Almahmeed W; Azar S; Okkeh O; Bramlage P; Jünger C; Halawa I; Ambegaonkar B; Wajih S; Brudi P
PLoS One; 2014; 9(1):e84350. PubMed ID: 24400085
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study.
Azar ST; Hantash HA; Jambart S; El-Zaheri MM; Rachoin R; Chalfoun A; Lahoud L; Okkeh O; Bramlage P; Brudi P; Ambegaonkar BM
Vasc Health Risk Manag; 2014; 10():225-35. PubMed ID: 24872710
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany.
Gitt AK; Jünger C; Smolka W; Bestehorn K
Clin Res Cardiol; 2010 Nov; 99(11):723-33. PubMed ID: 20521058
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): results of the Dyslipidemia International Study (DYSIS).
Viigimaa M; Erglis A; Latkovskis G; Mäeots E; Petrulionienė Ž; Šlapikas R; Gocentiene A; Bramlage P; Brudi P
Medicina (Kaunas); 2014; 50(1):44-53. PubMed ID: 25060204
[TBL] [Abstract][Full Text] [Related]
5. Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).
Drexel H; Chazelle F; Fauer C; Lautsch D; Gitt AK
Wien Klin Wochenschr; 2011 Oct; 123(19-20):611-7. PubMed ID: 21947362
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of persistent lipid abnormalities in statin-treated patients: Belgian results of the Dyslipidaemia International Study (DYSIS).
Devroey D; Radermecker RP; Van der Schueren BJ; Torbeyns B; Jaken RJ
Int J Clin Pract; 2014 Feb; 68(2):180-7. PubMed ID: 24308644
[TBL] [Abstract][Full Text] [Related]
7. [Dyslipemia in diabetics treated with statins. Results of the DYSIS study in Spian].
Millán J; Alegría E; Guijarro C; Lozano JV; Vitale GC; González-Timón B; González-Juanatey JR
Med Clin (Barc); 2013 Nov; 141(10):430-6. PubMed ID: 23246165
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS).
Goodman SG; Langer A; Bastien NR; McPherson R; Francis GA; Genest JJ; Leiter LA;
Can J Cardiol; 2010 Nov; 26(9):e330-5. PubMed ID: 21076724
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
Gitt AK; Lautsch D; Ferrieres J; Kastelein J; Drexel H; Horack M; Brudi P; Vanneste B; Bramlage P; Chazelle F; Sazonov V; Ambegaonkar B
Atherosclerosis; 2016 Dec; 255():200-209. PubMed ID: 27667299
[TBL] [Abstract][Full Text] [Related]
10. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).
Zhao S; Wang Y; Mu Y; Yu B; Ye P; Yan X; Li Z; Wei Y; Ambegaonakr BM; Hu D;
Atherosclerosis; 2014 Aug; 235(2):463-9. PubMed ID: 24950001
[TBL] [Abstract][Full Text] [Related]
12. Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
Wei Y; Guo H; The E; Che W; Shen J; Hou L; Zhao S; Ye P; Li G; Wang D; Jie Q; Hu D
Int J Cardiol; 2015 Mar; 182():469-75. PubMed ID: 25612824
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
Gitt AK; Lautsch D; Ferrières J; De Ferrari GM; Vyas A; Baxter CA; Bash LD; Ashton V; Horack M; Almahmeed W; Chiang FT; Poh KK; Brudi P; Ambegaonkar B
Atherosclerosis; 2017 Nov; 266():158-166. PubMed ID: 29028484
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of dyslipidaemia in statin-treated patients in South Africa: results of the DYSlipidaemia International Study (DYSIS).
Raal FJ; Blom DJ; Naidoo S; Bramlage P; Brudi P
Cardiovasc J Afr; 2013 Sep; 24(8):330-8. PubMed ID: 24240385
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk distribution of residual dyslipidemia in statin-treated patients in Greece.
Liberopoulos E; Vlasserou F; Mitrogianni Z; Papageorgantas I; Elisaf M;
Angiology; 2012 Apr; 63(3):184-93. PubMed ID: 21676964
[TBL] [Abstract][Full Text] [Related]
16. Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS).
Marques da Silva P; Massano Cardoso S; Ferreira AM;
Prim Care Diabetes; 2015 Aug; 9(4):283-9. PubMed ID: 25449144
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.
Strang AC; Kaasjager HA; Basart DC; Stroes ES
Neth J Med; 2010 Apr; 68(4):168-74. PubMed ID: 20421658
[TBL] [Abstract][Full Text] [Related]
18. Frequency and predictors of cholesterol target attainment in patients with stable coronary heart disease in Belgium: results from the Dyslipidemia International Study II (DYSIS II
Hermans MP; Gevaert S; Descamps O; Missault L; Gillot B; De Keyzer D; Lautsch D; Brudi P; Ambegaonkar B; Vyas A; Horack M; Gitt A
Acta Clin Belg; 2019 Dec; 74(6):399-404. PubMed ID: 30355016
[No Abstract] [Full Text] [Related]
19. Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy.
Zhao W; Zheng XL; Jiang ZN; Liao XB; Zhao SP
Int J Cardiol; 2017 Dec; 248():355-360. PubMed ID: 28689987
[TBL] [Abstract][Full Text] [Related]
20. Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patients.
Sudano I; Hess L; Noll G; Arnet D
Swiss Med Wkly; 2011; 141():w13200. PubMed ID: 21574067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
